Company Neovasc Inc Toronto S.E.
Equities
CA64065J2056
Advanced Medical Equipment & Technology
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sarah Gallagher
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-12 |
Shmuel Banai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alexei J. Marko
BRD | Director/Board Member | 56 | 03-06-11 |
Investor Relations Contact | 54 | 07-04-01 | |
Lisa Becker
LAW | General Counsel | - | 21-07-12 |
John Panton
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
CHM | Chairman | 63 | 08-01-31 |
Paul Geyer
BRD | Director/Board Member | 61 | 00-11-01 |
Alexei J. Marko
BRD | Director/Board Member | 56 | 03-06-11 |
Douglas Janzen
BRD | Director/Board Member | 56 | 05-06-01 |
Norman J. Radow
BRD | Director/Board Member | - | 19-09-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,783,553 | 2,556,708 ( 91.85 %) | 0 | 91.85 % |
Company contact information
![address Neovasc Inc](https://cdn.zonebourse.com/static/address/46321427.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+4.88% | 217B | |
+7.12% | 191B | |
+27.49% | 154B | |
+33.11% | 112B | |
+1.22% | 62.75B | |
+18.39% | 53.34B | |
+1.45% | 48.88B | |
-4.22% | 39.36B | |
+3.16% | 35.73B |